The Evithrom Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The Evithrom Market has seen a historical compound annual growth rate (HCAGR) of XX. The market was worth $XX million in 2024 and it's projected to increase to $XX million in 2025, with a CAGR of XX%.
The Evithrom Market predicts that the market will reach a size of $XX million by 2029, with a compound annual growth rate (CAGR) of XX%.
Download Your Free Sample of the 2025 Evithrom Market Report and Uncover Key Trends Now!Key growth drivers of the evithrom market include:
• Rising incidence of bleeding disorders worldwide
• Improved diagnosis and increased awareness of bleeding disorders
• Genetic factors and aging population leading to higher recognition of these conditions
• The use of Esperoct in treating bleeding disorders like hemophilia A
The evithrom market covered in this report is segmented –
1) By Indication: Surgical Hemostasis, Trauma Care
2) By Formulation: Bovine Thrombin, Human Thrombin, Recombinant Thrombin
3) By Distribution Channel: Hospitals, Clinics and Diagnostic Centers, Online Pharmacies
Market trends in the evithrom market include:
• Technological advancements in fibrin sealants are emerging in the market.
• Adoption of minimally invasive innovations related to hemostasis and tissue sealing agents is trending.
• There is a rising trend of developments in medical technology in the evithrom market.
• Strategic collaborations between biotechnology firms are significantly shaping the market future.
The top competitors and leading players in the evithrom market are:
• Novo Nordisk A/S
North America was the largest region in the evithrom market in 2024